Novel bone mineralization proteins, DNA, vectors expression systems
First Claim
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding human LMP, wherein the nucleic acid molecule hybridizes under standard conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 25, and wherein the molecule hybridizes under highly stringent conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO;
26.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to isolated nucleic acid molecules that encode LIM mineralization protein, or LMP. The invention further provides vectors comprising nucleotide sequences that encode LMP, as well as host cells comprising those vectors. Moreover, the present invention relates to methods of inducing bone formation by transfecting osteogenic precursor cells with an isolated nucleic acid molecule comprising a nucleotide sequence encoding LIM mineralization protein. The transfection may occur ex vivo or in vivo by direct injection of virus or naked plasmid DNA. In a particular embodiment, the invention provides a method of fusing a spine by transfecting osteogenic precursor cells with an isolated nucleic acid molecule having a nucleotide sequence encoding LIM mineralization protein, admixing the transfected osteogenic precursor cells with a matrix and contacting the matrix with the spine. Finally, the invention relates to methods for inducing systemic bone formation by stable transfection of host cells with the vectors of the invention.
-
Citations
48 Claims
-
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding human LMP, wherein the nucleic acid molecule hybridizes under standard conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 25, and wherein the molecule hybridizes under highly stringent conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO;
26. - View Dependent Claims (2, 3, 8, 9, 10)
- 25, and wherein the molecule hybridizes under highly stringent conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO;
-
4. A human LMP protein encoded by an isolated nucleic acid molecule, wherein the nucleic acid molecule hybridizes under standard conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 25, and wherein the molecule hybridizes under highly stringent conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO;
26. - View Dependent Claims (5)
- 25, and wherein the molecule hybridizes under highly stringent conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO;
-
6. An isolated nucleic acid molecule comprising a nucleotide sequence encoding rat LMP protein, wherein the isolated nucleic acid molecule hybridizes under standard conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 2.
-
7. A rat LMP protein encoded by an isolated nucleic acid molecule, wherein the isolated nucleic acid molecule hybridizes under standard conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 2.
-
11. A human LIM mineralization protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 10 and SEQ ID NO;
34.
- 10 and SEQ ID NO;
-
12. A rat LIM mineralization protein comprising the amino acid sequence of SEQ ID NO:
- 1.
- 13. An osteoinductive soluble factor induced by the expression of human LIM mineralization protein.
- 15. A monoclonal antibody specific for a human LIM mineralization protein.
- 18. A polyclonal antibody specific for a human LIM mineralization protein.
-
21. A monoclonal antibody specific for a rat LIM mineralization protein (SEQ ID NO:
- 1).
-
22. A polyclonal antibody specific for a rat LIM mineralization protein (SEQ ID NO:
- 1).
- 23. A method of inducing bone formation comprising transfecting osteogenic precursor cells with an isolated nucleic acid molecule comprising a nucleotide sequence encoding LIM mineralization protein.
-
35. A method of fusing a spine, comprising:
-
(a) transfecting osteogenic precursor cells with an isolated nucleic acid molecule comprising a nucleotide sequence encoding LIM mineralization protein;
(b) admixing the transfected osteogenic precursor cells with a matrix; and
(c) contacting the matrix with the spine;
wherein expression of the nucleotide sequence encoding LIM mineralization protein causes mineralized bone formation in the matrix. - View Dependent Claims (36, 37)
-
-
38. A method of inducing systemic bone formation in a mammalian host in need thereof, comprising:
-
(a) transfecting osteogenic precursor cells with a vector that is stablely maintained in the osteogenic precursor cells, the vector comprising a nucleotide sequence encoding a LIM mineralization protein and a regulatable promoter, wherein the regulatable promoter, which responds to an exogenous control compound, controls expression of the nucleotide sequence encoding the LIM mineralization protein; and
(b) administering to the host, as needed, an amount of the exogenous control substance effective to cause expression of the nucleotide sequence encoding a LIM mineralization protein. - View Dependent Claims (39)
-
-
40. A method of stimulating production of an osteogenic soluble factor by an osteogenic cell, comprising:
-
(a) transfecting the osteogenic cell with an isolated nucleic acid molecule comprising a nucleotide sequence encoding LIM mineralization protein; and
(b) overexpressing the isolated nucleic acid molecule. - View Dependent Claims (41, 42)
-
- 43. A method of inhibiting the expression of LIM mineralization protein comprising transfecting a cell wherein the LIM mineralization protein is expressed with an antisense oligonucleotide.
-
45. An isolated nucleic acid molecule comprising a nucleotide sequence encoding human LMP, wherein the nucleic acid molecule hybridizes under standard conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 25.
-
46. An isolated nucleic acid molecule comprising a nucleotide sequence encoding human LMP, wherein the nucleic acid molecule hybridizes under highly stringent conditions to a nucleic acid molecule complementary to the full length of SEQ. ID NO:
- 26.
Specification